器官医学的发展现状和展望

张明熙; 赵强; 何晓顺

doi:10.3981/j.issn.1000-7857.2023.19.019

PDF(851 KB)

科技导报 ›› 2023, Vol. 41 ›› Issue (19) : 160-165. DOI: 10.3981/j.issn.1000-7857.2023.19.019

专题：创新引领自立自强——打造高质量科技创新策源地

器官医学的发展现状和展望

作者信息 -

中山大学附属第一医院，广州 510000

作者简介:

张明熙，硕士研究生，研究方向为无缺血肝移植，电子信箱：zmx991026@163.com；何晓顺（通信作者），主任医师，研究方向为无缺血器官移植，电子信箱：gdtrc@163.com

Current status and prospect of organ medicine

Author information -

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China

摘要

器官是人体发挥独立生理功能的基本单元，也是各类疾病发生的场所。基于疾病器官目前缺乏精确医疗的现状，器官医学理念应运而生。回顾了器官医学理念提出的背景，探讨了器官医学的已有成果及器官医学对于多学科的推动作用，展望了器官医学将推动医学研究、医疗器械领域发展，促进创新药物研发，并与其他领域实现交叉融合的发展前景。

Abstract

Organ medicine makes up for the shortcomings of current medical research and treatment methodology and helps to achieve new breakthroughs in medical research thinking and mode. It is expected to produce a number of research results that have not been achieved by existing medical research methods, so as to further promote the transformation of medical devices, innovative drug research and medical education, and develop innovative products with broad market prospects. It will lay a foundation for China to seize the commanding heights of innovative core technologies in the field of medicine in the future international strategic competition, which is of great significance for the emergence of organ medicine related new disciplines and industries in the field of life science, promoting the technological upgrading of China's medical and pharmaceutical industry, and promoting Chinese medicine to enter the international leading ranks.

导出引用

张明熙, 赵强, 何晓顺. 器官医学的发展现状和展望[J]. 科技导报, 2023, 41(19): 160-165 https://doi.org/10.3981/j.issn.1000-7857.2023.19.019

ZHANG Mingxi, ZHAO Qiang, HE Xiaoshun. Current status and prospect of organ medicine[J]. Science & Technology Review, 2023, 41(19): 160-165 https://doi.org/10.3981/j.issn.1000-7857.2023.19.019

参考文献

[1] Zhao Q, Nie Y, Guo Z, et al. The future of organ-oriented research and treatment[J]. Hepatobiliary Surgery and Nutrition, 2019, 8(5): 502-505.
[2] He X, Ji F, Zhang Z, et al. Combined liver-kidney perfusion enhances protective effects of normothermic perfusion on liver grafts from donation after cardiac death[J].Liver Transplantation, 2018, 24(1): 67-79.
[3] Morris P J. Transplantation: A medical miracle of the 20th century[J]. New England Journal of Medicine, 2004,351(26): 2678-2680.
[4] Eltzschig H K, Eckle T. Ischemia and reperfusion—frommechanism to translation[J]. Nature Medicine, 2011, 17(11): 1391-1401.
[5] de Rougemont O, Dutkowski P, Clavien P A. Biological modulation of liver ischemia-reperfusion injury[J]. Current Opinion in Organ Transplantation, 2010, 15(2): 183-189.
[6] de Meijer V E, Fujiyoshi M, Porte R J. Ex situ machine perfusion strategies in liver transplantation[J]. Journal of Hepatology, 2019, 70(1): 203-205.
[7] van Rijn R, Schurink I J, de Vries Y, et al. Hypothermic machine perfusion in liver transplantation: A randomized trial[J]. New England Journal of Medicine, 2021, 384(15):1391-1401.
[8] Markmann J F, Abouljoud M S, Ghobrial R M, et al. Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: The OCS liver PROTECT randomized clinical trial[J]. JAMA Surgery,2022, 157(3): 189-198.
[9] He X, Guo Z, Zhao Q, et al. The first case of ischemia‐free organ transplantation in humans: A proof of concept[J]. American Journal of Transplantation, 2018, 18(3):737-744.
[10] Guo Z, Xu J, Huang S, et al. Abrogation of graft isch‐emia‐reperfusion injury in ischemia‐free liver transplan‐tation[J]. Clinical and Translational Medicine, 2022, 12(4): e546.
[11] He X, Chen G, Zhu Z, et al. The first case of ischemiafree kidney transplantation in humans[J]. Frontiers in Medicine, 2019, doi: 10.3389/fmed.2019.00276.
[12] Yin S, Rong J, Chen Y, et al. Transplantation of a beating heart: A first in man[J]. The Lancet Regional Health-Western Pacific, 2022, 23: 100449.
[13] Ceresa C D L, Nasralla D, Pollok J M, et al. Machine perfusion of the liver: Applications in transplantation and beyond[J]. Nature Reviews Gastroenterology & Hepatology, 2022, 19(3): 199-209.
[14] Sampaziotis F, Muraro D, Tysoe O C, et al. Cholangio‐cyte organoids can repair bile ducts after transplantation in the human liver[J]. Science, 2021, 371(6531): 839-846.
[15] Bang J Y, Arnoletti J P, Holt B A, et al. An endoscopic transluminal approach, compared with minimally invasive surgery, reduces complications and costs for patients with necrotizing pancreatitis[J]. Gastroenterology, 2019, 156(4): 1027-1040.
[16] van Dijk A H, Wennmacker S Z, de Reuver P R, et al.Restrictive strategy versus usual care for cholecystecto‐my in patients with gallstones and abdominal pain (SE‐CURE): A multicentre, randomised, parallel-arm, noninferiority trial[J]. The Lancet, 2019, 393(10188): 2322-2330.
[17] Giger U, Frésard I, Häfliger A, et al. Laparoscopic training on Thiel human cadavers: A model to teach advanced laparoscopic procedures[J]. Surgical Endoscopy,2008, 22: 901-906.
[18] Wyles S M, Miskovic D, Ni Z, et al. Analysis of laboratory-based laparoscopic colorectal surgery workshops with‐in the English National Training Programme[J]. Surgical Endoscopy, 2011, 25: 1559-1566.
[19] Wang X, Zhang K, Hu W, et al. A new platform for laparoscopic training: Initial evaluation of the ex-vivo live multivisceral training device[J]. Surgical Endoscopy,2021, 35: 374-382.